Hirofumi Hamada
Impact in
- Genetics top 0.1%
- Mesenchymal stem cell research
- Virus-based gene therapy research
- Developmental Neuroscience top 0.5%
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Cancer Research and Treatments 35
- Genetics 90
- Virus-based gene therapy research 88
- Mesenchymal stem cell research 23
- Co-authors
- Ken‐ichi HanadaHiromitsu NakauchiMasatake OsawaOsamu HonmouKiyohiro HoukinMasayoshi KobuneTakashi TsuruoJeffery D. Kocsis
- Journals
- Biochemical and Biophysical Research Communications (18 papers)Cancer Gene Therapy (13 papers)The Journal of Gene Medicine (9 papers)Molecular Therapy (9 papers)Blood (8 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hirofumi Hamada
226 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Genetics 2.8k
- Developmental Neuroscience 869
- Hematology 1.5k
- Oncology 2.7k
- Immunology 2.0k
Countries citing papers authored by Hirofumi Hamada
This map shows the geographic impact of Hirofumi Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Hamada more than expected).
Fields of papers citing papers by Hirofumi Hamada
This network shows the impact of papers produced by Hirofumi Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Hamada. The network helps show where Hirofumi Hamada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirofumi Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 17 | |
| 2 | 2009 | 241 | |
| 3 | 2003 | 11 | |
| 4 | 2003 | 284 | |
| 5 | Co-transduction of p27Kip1 strongly augments Fas ligand- and caspase-8-mediated apoptosis in U-373MG glioma cells. | 2002 | 6 |
| 6 | 2002 | 21 | |
| 7 | 2002 | 18 | |
| 8 | 2001 | 26 | |
| 9 | 2001 | 14 | |
| 10 | 2000 | 18 | |
| 11 | 1999 | 64 | |
| 12 | 1999 | 4 | |
| 13 | Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas. | 1999 | 79 |
| 14 | 1999 | 141 | |
| 15 | 1997 | 32 | |
| 16 | 1995 | 35 | |
| 17 | 1992 | 10 | |
| 18 | 1989 | 21 | |
| 19 | 1989 | 8 | |
| 20 | Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies. | 1988 | 54 |
About Hirofumi Hamada
Hirofumi Hamada is a scholar working on Biotechnology, Genetics, Oncology, Genetics and Immunology, having authored 227 papers that have together received 11.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (88 papers), RNA Interference and Gene Delivery (52 papers), CAR-T cell therapy research (46 papers), Cancer Research and Treatments (35 papers), Immunotherapy and Immune Responses (31 papers), Cell death mechanisms and regulation (23 papers), Mesenchymal stem cell research (23 papers) and Viral Infectious Diseases and Gene Expression in Insects (18 papers). The work is most often cited by research in Genetics (2.8k citations), Developmental Neuroscience (869 citations), Hematology (1.5k citations), Oncology (2.7k citations) and Immunology (2.0k citations). Hirofumi Hamada has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Ken‐ichi Hanada, Hiromitsu Nakauchi, Masatake Osawa, Osamu Honmou, Kiyohiro Houkin, Masayoshi Kobune, Takashi Tsuruo, Jeffery D. Kocsis, Kiminori Nakamura and Takaaki Kirino. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Gene Therapy, The Journal of Gene Medicine, Molecular Therapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.